OOIR: Observatory of International Research

Papers

(The H4-Index of Endocrine is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Diagnosis of hepatic steatosis and steatohepatitis in people with new-onset type 2 diabetes: a multidisciplinary approach	112
Residual risks of comorbidities after parathyroidectomy in a nationwide cohort of patients with primary hyperparathyroidism	96
Adaptation and validation of an artificial intelligence based digital radiogrammetry tool for assessing bone health of indian children and youth with type-1 diabetes	72
Determinants of the uptake of the uncinate process of pancreas in 68Ga-DOTATOC PET/CT: a retrospective study	62
Glucose transporter 4 mRNA expression in subcutaneous adipose tissue of women with PCOS remains unchanged despite metformin withdrawal: is there a cellular metabolic treatment legacy effect?	60
Interaction effect of blood glucose and pressure on the risk of chronic kidney disease: a population-based prospective cohort study	54
Eighth International Adrenal Cancer Symposium Brescia, Italy, September 30 to October 1–2, 2021	53
An unusual brain lesion in a patient with Laron Syndrome	50
The detection of pathological parathyroid glands is facilitated by identifying vascular features on ultrasound: the potential benefit of a low-frequency vascular probe	49
A noninvasive scoring model for the differential diagnosis of ACTH-dependent Cushing’s syndrome: a retrospective analysis of 311 patients based on easy-to-use parameters	46
Contrast CT radiomic features add value to prediction of prognosis in adrenal cortical carcinoma	46
Aldosterone and renin concentrations were abnormally elevated in a cohort of normotensive pregnant women	45
Nongenetic risk factors for thyroid cancer: an umbrella review of evidence	40
Co-expression of multiple transcription factors is associated with clinical features and endocrine prognosis in growth hormone-secreting pituitary adenomas	38
Combined LT3 and LT4 therapy for precision medicine: easier with TTCombo system	38
Normocalcemic primary hyperparathyroidism is not associated with cardiometabolic alterations	38
Impact of delayed surgery in differentiated thyroid carcinoma and medullary thyroid carcinoma	37
Risk factors and outcomes of Graves’ orbitopathy after radioactive iodine therapy	37
Open-source automated insulin delivery systems (OS-AIDs) in a pediatric population with type 1 diabetes in a real-life setting: the AWeSoMe study group experience	35
Mutation screening of eight genes and comparison of the clinical data in a Chinese cohort with congenital hypothyroidism	34
Hematological toxicities with Lutathera® for neuroendocrine neoplasms: post-marketing surveillance data from the US-FDA	33
Predictors of bone mineral density in patients receiving glucocorticoid replacement for Addison’s disease	32
A systematic review of dysregulated microRNAs in Hashimoto’s thyroiditis	31
A novel in vitro assay to study chondrocyte-to-osteoblast transdifferentiation	30
Non-classical congenital adrenal hyperplasia: current insights into clinical implications, diagnosis and treatment	30

A proposed grading scheme for predicting recurrence in medullary thyroid cancer based on the Ki67 index and metastatic lymph node ratio	28
Enhancing patient-centered care with AI: a study of responses to neuroendocrine neoplasms queries	28
Prognostic significance of laterality in lung neuroendocrine tumors	28
Relation of serum irisin levels with adiposity, components of metabolic syndrome and carotid intima media thickness in prepubertal children with obesity: a cross-sectional study	28